Vitiligo and alopecia areata: apples and oranges?

被引:52
作者
Harris, John E. [1 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Med, Div Dermatol, Worcester, MA 01605 USA
基金
美国国家卫生研究院;
关键词
adaptive immunity; alopecia areata; autoantigen; autoimmunity; cytokine; IFN-; innate immunity; T cell; treatment; vitiligo; NECROSIS-FACTOR-ALPHA; UNFOLDED PROTEIN RESPONSE; T-CELLS; GENERALIZED VITILIGO; MOUSE MODEL; AUTOIMMUNE-DISEASE; OXIDATIVE STRESS; MEDICAL PROGRESS; IMMUNE-RESPONSE; GROWTH-FACTOR;
D O I
10.1111/exd.12264
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Vitiligo and alopecia areata are common autoimmune diseases of the skin. Vitiligo is caused by the destruction of melanocytes and results in the appearance of white patches on any part of the body, while alopecia areata is characterized by patchy hair loss primarily on the scalp, but may also involve other areas as well. At first glance, the two diseases appear to be quite different, targeting different cell types and managed using different treatment approaches. However, the immune cell populations and cytokines that drive each disease are similar, they are closely associated within patients and their family members, and vitiligo and alopecia areata have common genetic risk factors, suggesting that they share a similar pathogenesis. Like apples and oranges, vitiligo and alopecia areata have some obvious differences, but similarities abound. Recognizing both similarities and differences will promote research into the pathogenesis of each disease, as well as the development of new treatments.
引用
收藏
页码:785 / 789
页数:5
相关论文
共 73 条
[1]   Colocalization of alopecia areata and vitiligo [J].
Adams, BB ;
Lucky, AW .
PEDIATRIC DERMATOLOGY, 1999, 16 (05) :364-366
[2]  
AlGhamdi KM, 2012, J DRUGS DERMATOL, V11, P534
[3]   Worsening of Vitiligo and Onset of New Psoriasiform Dermatitis following Treatment with Infliximab [J].
AlGhamdi, Khalid M. ;
Khurrum, Huma ;
Rikabi, Ammar .
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2011, 15 (05) :280-284
[4]  
[Anonymous], 2009, LEVERS HISTOPATHOLOG
[5]   Comparing apples and oranges: a randomised prospective study [J].
Barone, JE .
BRITISH MEDICAL JOURNAL, 2000, 321 (7276) :1569-1570
[6]   Role of interleukin-17 in the pathogenesis of vitiligo [J].
Bassiouny, D. A. ;
Shaker, O. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2011, 36 (03) :292-297
[7]  
Bin Dayel S, 2013, J DRUGS DERMATOL, V12, P159
[8]   Increased tumor necrosis factor alpha (TNF-α) and interleukin 1 alpha (IL1-α) levels in the lesional skin of patients with nonsegmental vitiligo [J].
Birol, Ahu ;
Kisa, Ucler ;
Kurtipek, Gulcan Saylam ;
Kara, Fatma ;
Kocak, Mukadder ;
Erkek, Emel ;
Caglayan, Osman .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2006, 45 (08) :992-993
[9]   Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans [J].
Carroll, JM ;
McElwee, KJ ;
King, LE ;
Byrne, MC ;
Sundberg, JP .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (02) :392-402
[10]   Comorbidity profiles among patients with alopecia areata: The importance of onset age, a nationwide population-based study [J].
Chu, Szu-Ying ;
Chen, Yi-Ju ;
Tseng, Wei-Cheng ;
Lin, Ming-Wei ;
Chen, Tzeng-Ji ;
Hwang, Chian-Yaw ;
Chen, Chih-Chiang ;
Lee, Ding-Dar ;
Chang, Yun-Ting ;
Wang, Wen-Jen ;
Liu, Han-Nan .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 65 (05) :949-956